ABUS vs DIS · P/E 5.4, rev $6.2M vs P/E 16, rev $94.42B
Arbutus Biopharma Corp (ABUS) versus Walt Disney Company (DIS) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Walt Disney Company (DIS) is a entertainment company listed on NYSE. It is led by Bob Iger.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported DIS revenue for 2025-09-27 was $94.42B. Net income was $12.40B. DIS currently screens at market cap $175.14B and trailing P/E 16.1.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. DIS currently screens at market cap $175.14B and trailing P/E 16.1.
Not investment advice. Open the ABUS and DIS stock pages for the full models.
Not investment advice.